Who has invested in Topas Therapeutics?

Vesalius BioCapital III, BioMedPartners are named among the investors backing Topas Therapeutics.

Topas Therapeutics Funding: $26M Raised, Series B (2018)

Topas Therapeutics funding overview

Topas Therapeutics is based in Hamburg, Germany. Topas Therapeutics has raised $26M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2018. The round record for Topas Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include Vesalius BioCapital III, BioMedPartners. 2 distinct backers are named across the disclosed rounds.

Topas Therapeutics at a glance

Total raised: $26M
Latest round: Series B
Latest round date: June 2018
Headquarters: Hamburg, Germany
Notable investors: Vesalius BioCapital III, BioMedPartners

Frequently asked about Topas Therapeutics funding

How much has Topas Therapeutics raised?: Topas Therapeutics has raised $26M in total disclosed funding across the rounds on record.
Who has invested in Topas Therapeutics?: Vesalius BioCapital III, BioMedPartners are named among the investors backing Topas Therapeutics.
What was the latest Topas Therapeutics funding round?: The most recent disclosed round is a Series B, announced in June 2018.
Where is Topas Therapeutics based?: Topas Therapeutics is based in Hamburg, Germany.
When did Topas Therapeutics last raise?: The last disclosed Topas Therapeutics round closed in June 2018 at Series B.

Topas Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Hamburg below to benchmark round size and investor mix.

Topas Therapeutics Funding: $26M Raised, Series B (2018)

Topas Therapeutics funding overview

Topas Therapeutics at a glance

Frequently asked about Topas Therapeutics funding

Companies related to Topas Therapeutics (14)

Browse related funding lists (4)